11 completed, 9 recruiting, 8 unknown, 3 not yet recruiting. 33 Phase 2, 10 Phase 3, 6 Phase 1.
Follow Monash University: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| bNAbs and Anti-PD-1 in HIV 3BNC117-LS, 10-1074-LS, Nivolumab - HIV-1 | Phase 2 | Not yet recruiting | Ole Schmeltz Søgaard | 90 | 2026-09-15 | 2026-09-15 |
| The AminoECMO Pilot Trial Synthamin-17 (10% amino acid solution), Placebo (Hartmann's balanced crystalloid solution) - Acute Kidney Injury | Phase 2 | Not yet recruiting | Australian and New Zealand Intensive Care Research Centre | 40 | 2026-02-01 | 2026-02-27 |
| Anakinra Pilot 2 - A Study to Optimise Dose and Route of Administration of Anakinra in Preterm Infants Anakinra (Kineret®) - Premature Infants, Very Premature Infants | Phase 2 | Recruiting | Monash Medical Centre | 24 | 2025-06-27 | 2025-11-28 |
| Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig) Trimethoprim / Sulfamethoxazole, Immune Globulin Intravenous - Myeloma, Non Hodgkin's Lymphoma | Phase 2 / Phase 3 | Recruiting | Monash University | 900 | 2025-05-07 | 2025-10-07 |
| Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT) Intravenous immunoglobulin, Trimethoprim / Sulfamethoxazole, Amoxicillin clavulanic acid - Myeloma, Non-Hodgkin's Lymphoma | Phase 2 / Phase 3 | Recruiting | Monash University | 900 | 2025-05-06 | 2025-10-07 |
| Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig) Trimethoprim Sulfamethoxazole, Amoxycillin/clavulanic acid, Immune Globulin Intravenous - Myeloma, Leukemia | Phase 2 / Phase 3 | Recruiting | Monash University | 900 | 2025-05-06 | 2025-10-07 |
| Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig) Immune Globulin Intravenous - Myeloma, Non Hodgkin's Lymphoma | Phase 2 / Phase 3 | Recruiting | Monash University | 900 | 2025-04-28 | 2025-10-07 |
| Skincubator, a Novel Incubator for Skin to Skin Contact Feasibility Study Skincubator 2 - Preterm, Preterm Birth | Phase 2 / Phase 3 | Not yet recruiting | Itamar Nitzan | 50 | 2024-08-31 | 2024-08-09 |
| A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers NAC, Placebo - Huntington Disease | Phase 2 | Recruiting | Western Sydney Local Health District | 160 | 2024-06-01 | 2025-02-28 |
| MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder Prolonged exposure therapy, MDMA, Niacin - PTSD, Alcohol Use Disorder | Phase 2 | Unknown | University of Sydney | 120 | 2023-09-19 | 2023-11-07 |
| Deep sequencIng in Cutaneous Squamous CEll caRciNomas Cemiplimab - Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck | Phase 2 | Active not recruiting | Peter MacCallum Cancer Centre, Australia | 11 | 2023-05-26 | 2026-09-21 |
| Intranasal Heparin Treatment to Reduce Transmission Among Household Contacts of COVID 19 Positive Adults and Children unfractionated heparin, 0.9%sodium chloride - COVID-19 | Phase 2 / Phase 3 | Completed | Murdoch Childrens Research Institute | 506 | 2023-01-30 | 2026-05-05 |
| Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension trimethoprim-sulfamethoxazole (co-trimoxazole), amoxycillin/clavulanic acid and ciprofloxacin, Immunoglobulins - Haematological Malignancy, Hypogammaglobulinemia | Phase 2 / Phase 3 | Recruiting | Monash University | 300 | 2022-11-30 | 2024-04-19 |
| Microbial Restoration in Inflammatory Bowel Diseases Antibiotics, Dietician designed diet, FMT - Fecal Microbiota Transplantation, Crohn Disease | Phase 1 / Phase 2 | Recruiting | St Vincent's Hospital Melbourne | 120 | 2022-05-01 | 2025-02-26 |
| Anakinra for Preterm Infants Pilot Anakinra - Prematurity; Extreme, Inflammation | Phase 1 / Phase 2 | Unknown | Monash Medical Centre | 25 | 2022-02-15 | 2024-09-19 |
| Evaluation of the Effectiveness of Cannabidiol in Treating Severe Behavioural Problems in Children and Adolescents With Intellectual Disability Cannabidiol Oil, Placebo - Intellectual Disability, Child Behavior Problem | Phase 2 | Completed | Murdoch Childrens Research Institute | 132 | 2021-05-11 | 2025-09-03 |
| Finding the Optimal Regimen for Mycobacterium Abscessus Treatment Amikacin, Tigecycline, Imipenem - Pulmonary Disease Due to Mycobacteria (Diagnosis) | Phase 2 / Phase 3 | Recruiting | The University of Queensland | 300 | 2020-03-02 | 2026-05-11 |
| Carnosine for Peripheral Vascular Disease Carnosine, Placebo - Peripheral Arterial Disease | Phase 2 | Unknown | Monash University | 104 | 2019-03-01 | 2020-12-29 |
| Trial of EXenatide in Acute Ischaemic Stroke Exenatide Injection - Acute Ischemic Stroke | Phase 2 | Unknown | Neuroscience Trials Australia | 350 | 2017-11-23 | 2021-09-14 |
| Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea Oral appliance, Oxygen, Oral appliance plus oxygen - Obstructive Sleep Apnea | Phase 2 | Completed | Brigham and Women's Hospital | 41 | 2017-09-06 | 2025-05-04 |
Showing 20 of 33. Sign in to see all of them.
Neoplasms (6) · Infections (5) · Leukemia (5) · Lymphoma (5) · Neoplasms, Plasma Cell (5) · Premature Birth (3) · Bronchopulmonary Dysplasia (2) · Cystic Fibrosis (2) · Heart Failure (2) · Inflammation (2) · Acquired Immunodeficiency Syndrome (1) · Acute Kidney Injury (1) · Agammaglobulinemia (1) · Alcoholism (1) · Arthritis, Rheumatoid (1)
Trimethoprim, Sulfamethoxazole Drug Combination (5) · Ciprofloxacin (3) · gamma-Globulins (3) · Amoxicillin-Potassium Clavulanate Combination (2) · Carnosine (2) · Immunoglobulins, Intravenous (2) · Interleukin 1 Receptor Antagonist Protein (2) · Oxygen (2) · Acetylcysteine (1) · Amikacin (1) · Amoxicillin (1) · Anti-Bacterial Agents (1) · Azithromycin (1) · Cannabidiol (1) · Cefoxitin (1)
Australia (28) · New Zealand (4) · China (3) · United States (3) · Denmark (2) · Singapore (2) · Austria (1) · Chile (1) · Czechia (1) · Finland (1) · India (1) · Israel (1) · Italy (1) · Netherlands (1) · Portugal (1)
Zoe McQuilten, Professor (4) · Claudia Nold, Prof (2) · Gergely Toldi, Dr (2) · Rod Hunt, Prof (2) · Annette M Lim, MBBS, FRACP, PhD (1) · Arthur Mark Richards, MBChB, MD (Distinction), PhD (1) · Bradley A Edwards, PhD (1) · Carl Kirkpatrick, Prof (1) · Carol Hodgson, FAHMS (1) · Carolyn Lam Su Ping, MBBS, MRCP, MS (1) · Carolyn Orr (1) · Christopher Bladin (1) · Clement Loy (1)
PMID 16630205, PMID 21195036, PMID 26423811, PMID 26614966, PMID 26696749, PMID 28864708, PMID 29684433, PMID 30830886, PMID 31537547, PMID 33687069, PMID 34116715, PMID 34482353, PMID 35250032, PMID 36355371, PMID 36389766, PMID 38004228, PMID 38011235, PMID 38649069, PMID 39482484, PMID 39599686, PMID 39688178, PMID 39770949, PMID 40254304, PMID 41767833, PMID 42409408
2018 (1), 2025 (1), K24AI069994 (1), R01HL128658 (1)